Ameriprise’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.97M | Buy |
109,237
+89,940
| +466% | +$3.27M | ﹤0.01% | 2523 |
|
|
2025
Q1 | $699K | Buy |
19,297
+5,901
| +44% | +$214K | ﹤0.01% | 3339 |
|
|
2024
Q4 | $564K | Buy |
13,396
+1,039
| +8% | +$43.7K | ﹤0.01% | 3457 |
|
|
2024
Q3 | $686K | Buy |
12,357
+578
| +5% | +$32.1K | ﹤0.01% | 3359 |
|
|
2024
Q2 | $484K | Sell |
11,779
-1,889
| -14% | -$77.6K | ﹤0.01% | 3420 |
|
|
2024
Q1 | $638K | Buy |
13,668
+2,592
| +23% | +$121K | ﹤0.01% | 3339 |
|
|
2023
Q4 | $530K | Sell |
11,076
-4,417
| -29% | -$211K | ﹤0.01% | 3435 |
|
|
2023
Q3 | $552K | Sell |
15,493
-5,227
| -25% | -$186K | ﹤0.01% | 3372 |
|
|
2023
Q2 | $956K | Sell |
20,720
-37,775
| -65% | -$1.74M | ﹤0.01% | 3192 |
|
|
2023
Q1 | $2.35M | Buy |
58,495
+20,312
| +53% | +$815K | ﹤0.01% | 2768 |
|
|
2022
Q4 | $1.77M | Buy |
38,183
+22,092
| +137% | +$1.02M | ﹤0.01% | 2864 |
|
|
2022
Q3 | $667K | Buy |
16,091
+1,508
| +10% | +$62.5K | ﹤0.01% | 3286 |
|
|
2022
Q2 | $870K | Buy |
14,583
+10
| +0.1% | +$597 | ﹤0.01% | 3174 |
|
|
2022
Q1 | $1.06M | Sell |
14,573
-346
| -2% | -$25.1K | ﹤0.01% | 3191 |
|
|
2021
Q4 | $1.26M | Buy |
14,919
+224
| +2% | +$18.8K | ﹤0.01% | 3148 |
|
|
2021
Q3 | $1.33M | Sell |
14,695
-10,365
| -41% | -$935K | ﹤0.01% | 3035 |
|
|
2021
Q2 | $2.39M | Buy |
25,060
+848
| +4% | +$80.9K | ﹤0.01% | 2854 |
|
|
2021
Q1 | $2.76M | Sell |
24,212
-16,714
| -41% | -$1.9M | ﹤0.01% | 2728 |
|
|
2020
Q4 | $5.67M | Buy |
40,926
+17,730
| +76% | +$2.45M | ﹤0.01% | 2177 |
|
|
2020
Q3 | $1.91M | Buy |
23,196
+3,529
| +18% | +$290K | ﹤0.01% | 2693 |
|
|
2020
Q2 | $1.54M | Sell |
19,667
-6,420
| -25% | -$502K | ﹤0.01% | 2730 |
|
|
2020
Q1 | $1.16M | Buy |
26,087
+16,635
| +176% | +$738K | ﹤0.01% | 2756 |
|
|
2019
Q4 | $402K | Sell |
9,452
-892,376
| -99% | -$38M | ﹤0.01% | 3406 |
|
|
2019
Q3 | $38.6M | Sell |
901,828
-15,797
| -2% | -$676K | 0.02% | 782 |
|
|
2019
Q2 | $58.3M | Buy |
917,625
+89,865
| +11% | +$5.71M | 0.03% | 605 |
|
|
2019
Q1 | $57.4M | Sell |
827,760
-18,712
| -2% | -$1.3M | 0.03% | 593 |
|
|
2018
Q4 | $36.8M | Sell |
846,472
-385,801
| -31% | -$16.8M | 0.02% | 744 |
|
|
2018
Q3 | $94.1M | Sell |
1,232,273
-99,189
| -7% | -$7.57M | 0.03% | 492 |
|
|
2018
Q2 | $102M | Buy |
1,331,462
+132,431
| +11% | +$10.2M | 0.05% | 406 |
|
|
2018
Q1 | $61.1M | Buy |
1,199,031
+1,161,985
| +3,137% | +$59.2M | 0.03% | 560 |
|
|
2017
Q4 | $1.72M | Sell |
37,046
-9,517
| -20% | -$441K | ﹤0.01% | 2730 |
|
|
2017
Q3 | $2.48M | Sell |
46,563
-55,211
| -54% | -$2.94M | ﹤0.01% | 2501 |
|
|
2017
Q2 | $6.32M | Buy |
101,774
+7,229
| +8% | +$449K | ﹤0.01% | 1899 |
|
|
2017
Q1 | $6.41M | Sell |
94,545
-13,566
| -13% | -$919K | ﹤0.01% | 1852 |
|
|
2016
Q4 | $7.6M | Sell |
108,111
-65,708
| -38% | -$4.62M | ﹤0.01% | 1714 |
|
|
2016
Q3 | $12.3M | Sell |
173,819
-175,434
| -50% | -$12.4M | 0.01% | 1283 |
|
|
2016
Q2 | $17.1M | Buy |
349,253
+139,511
| +67% | +$6.82M | 0.01% | 1003 |
|
|
2016
Q1 | $13.3M | Sell |
209,742
-260,592
| -55% | -$16.5M | 0.01% | 1206 |
|
|
2015
Q4 | $52.8M | Buy |
470,334
+93,380
| +25% | +$10.5M | 0.03% | 454 |
|
|
2015
Q3 | $36.3M | Buy |
376,954
+264,457
| +235% | +$25.5M | 0.02% | 611 |
|
|
2015
Q2 | $11.5M | Buy |
112,497
+62,197
| +124% | +$6.37M | 0.01% | 1465 |
|
|
2015
Q1 | $3.12M | Buy |
50,300
+25,546
| +103% | +$1.59M | ﹤0.01% | 2360 |
|
|
2014
Q4 | $1.09M | Sell |
24,754
-21,547
| -47% | -$945K | ﹤0.01% | 2846 |
|
|
2014
Q3 | $2.62M | Sell |
46,301
-64,689
| -58% | -$3.66M | ﹤0.01% | 2385 |
|
|
2014
Q2 | $4.98M | Sell |
110,990
-49,543
| -31% | -$2.22M | ﹤0.01% | 2083 |
|
|
2014
Q1 | $7.85M | Buy |
+160,533
| New | +$7.85M | ﹤0.01% | 1713 |
|